QLS5133

· Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QLS5133, covering 2025-07-11 to 2025-07-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of QLS5133 Monotherapy in Advanced Solid Tumors [Phase 1, Phase 2]